| |
| |
|
| Insider
Information: |
Chang David D |
| Relationship: |
|
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,465,278 |
|
|
Indirect Shares
|
2,913,196 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,378,474 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kite Pharma, Inc. |
KITE |
EVP, R&D, Chief Medica... |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-03-14 |
4,465,278 |
2024-03-14 |
2,913,196 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2024-03-14 |
4 |
D |
$4.33 |
$231,192 |
D/D |
(53,393) |
4,465,278 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2024-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
317,800 |
4,513,203 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2023-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,924,464 |
4,193,911 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2023-03-14 |
4 |
D |
$5.56 |
$124,210 |
D/D |
(22,340) |
2,269,447 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2022-03-15 |
4 |
S |
$7.65 |
$180,879 |
D/D |
(23,648) |
2,289,652 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2021-05-24 |
4 |
OE |
$18.22 |
$499,410 |
D/D |
27,410 |
2,312,279 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
80,452 |
2,284,869 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2021-03-15 |
4 |
S |
$38.57 |
$791,271 |
D/D |
(20,513) |
2,204,417 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-08-31 |
4/A |
GA |
$0.00 |
$0 |
I/I |
411,556 |
856,044 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,187 |
2,224,101 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
9,198 |
1,201,108 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-03-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
856,044 |
650,266 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-03-16 |
4 |
S |
$19.24 |
$392,615 |
D/D |
(20,335) |
2,214,914 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,234,136 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,191,910 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,173,106 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,215,354 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,205,963 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-09-23 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,163,704 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,195,469 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-09-05 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,154,302 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,186,078 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-07-18 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,144,900 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,388 |
2,176,687 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2019-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
10,154 |
1,135,498 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
